Allogene Therapeutics, Inc. Business Finance Contracts & Agreements

18 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Allogene Therapeutics, Inc. Director Restricted Stock Unit Grant Notice (Amended and Restated 2018 Equity Incentive Plan)
Equity Distribution Agreements
Allogene Therapeutics, Inc.
Biotechnology
2025
Share Exchange Agreement among Allogene Overland Biopharm (CY) Limited, Overland Pharmaceuticals (CY) Inc., and Allogene Therapeutics, Inc. dated May 24, 2024
Exchange Agreements
Allogene Therapeutics, Inc.
Biotechnology
NY
2024
Amended and Restated Shareholders’ Agreement among Allogene Overland Biopharm (CY) Limited, Allogene Therapeutics, Inc., and HH BioPharma Holdings Ltd.
Shareholders Agreements
Allogene Therapeutics, Inc.
Biotechnology
NY
2024
Securities Purchase Agreement between Allogene Therapeutics, Inc. and Purchasers dated May 13, 2024
Purchase Agreements
Allogene Therapeutics, Inc.
Biotechnology
NY
2024
Allogene Therapeutics, Inc. Common Stock Underwriting Agreement with Goldman Sachs & Co. LLC (May 13, 2024)
Underwriting Agreements
Allogene Therapeutics, Inc.
Biotechnology
2024
Amendment No. 2 to Sales Agreement between Allogene Therapeutics, Inc. and Cowen and Company, LLC (November 2, 2023)
Equity Distribution Agreements
Allogene Therapeutics, Inc.
Biotechnology
NY
2023
Asset Contribution Agreement between Pfizer Inc. and Allogene Therapeutics, Inc. (April 2, 2018)
Contribution Agreements
Allogene Therapeutics, Inc.
Biotechnology
DE
2023
Description of Common Stock of Allogene Therapeutics, Inc.
Stock Agreements
Allogene Therapeutics, Inc.
Biotechnology
2023
First Amendment to Share Purchase Agreement among Allogene Overland Biopharm (CY) Limited, Overland Pharmaceuticals (CY) Inc., and Allogene Therapeutics, Inc.
Purchase Agreements
Allogene Therapeutics, Inc.
Biotechnology
2022
Shareholders’ Agreement among Allogene Overland Biopharm (CY) Limited, Allogene Therapeutics, Inc., and Overland Pharmaceuticals (CY) Inc. dated December 14, 2020
Shareholders Agreements
Allogene Therapeutics, Inc.
Biotechnology
NY
2021
Share Purchase Agreement among Allogene Overland Biopharm (CY) Limited, Overland Pharmaceuticals (CY) Inc., and Allogene Therapeutics, Inc. dated December 14, 2020
Purchase Agreements
Allogene Therapeutics, Inc.
Biotechnology
NY
2021
Allogene Therapeutics, Inc. Common Stock Underwriting Agreement with Goldman Sachs, Jefferies, and Cowen (June 2020)
Underwriting Agreements
Allogene Therapeutics, Inc.
Biotechnology
2020
Description of Common Stock of Allogene Therapeutics, Inc.
Stock Agreements
Allogene Therapeutics, Inc.
Biotechnology
2020
Asset Contribution Agreement between Pfizer Inc. and Allogene Therapeutics, Inc. (April 2, 2018)
Contribution Agreements
Allogene Therapeutics, Inc.
Biotechnology
DE
2018
Allogene Therapeutics, Inc. Common Stock Underwriting Agreement with Goldman Sachs, J.P. Morgan, Cowen, and Jefferies (2018)
Underwriting Agreements
Allogene Therapeutics, Inc.
Biotechnology
2018
Asset Contribution Agreement between Pfizer Inc. and Allogene Therapeutics, Inc. dated April 2, 2018
Contribution Agreements
Allogene Therapeutics, Inc.
Biotechnology
DE
2018
Allogene Therapeutics, Inc. Amended and Restated 2018 Equity Incentive Plan
Equity Distribution Agreements
Allogene Therapeutics, Inc.
Biotechnology
DE
2018
Allogene Therapeutics, Inc. Investors' Rights Agreement (April 6, 2018)
Investor Rights Agreements
Allogene Therapeutics, Inc.
Biotechnology
CA
2018